Boomerang

Boomerang

Early Stage

Digital health solution

Digital health solution

Overview

Raised to Date: Raised: $2,000

Total Commitments ($USD)

Platform

Title3Funds

Start Date

01/12/2023

Close Date

06/23/2023

Min. Goal
$10,000
Max. Goal
$5,000,000
Min. Investment

$250

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$10,000,000

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

06/22/2023

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$12

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2022

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

Low

Location

Irvine, California

Business Type

Growth

Boomerang, with a valuation of $10 million, is raising funds on Title3Funds. It is a digital health company focused on at-home diagnostic testing, customizable wellness plans, and strategic partnerships. The at-home test kits of Boomerang are convenient and accurate and span across tests, including diabetes, food sensitivity, food allergy, STDs, UTI, and COVID-19. Boomerang has a loyal customer base and expects to reach $25 million in revenue by 2023. Frank Gianotti founded Boomerang in October 2022. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5 million. The campaign proceeds will be used for marketing, equipment purchases, accounting fees, and general working capital.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 01/12/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Boomerang on Title3Funds 2023
Platform: Title3Funds
Security Type: Equity - Common
Valuation: $10,000,000
Price per Share: $1.00

Follow company

Follow Boomerang on Title3Funds 2023

Buy Boomerang's Deal Report

Warning: according to the close date for this deal, Boomerang may no longer be accepting investments.

Boomerang Deal Report

Get KingsCrowd’s comprehensive report on Boomerang including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Boomerang is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Boomerang deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge